The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The primary hyperoxalurias
Open accessAbstract
The primary hyperoxalurias are rare disorders of glyoxylate metabolism in which specific hepatic enzyme deficiencies result in overproduction of oxalate. Due to resulting severe hyperoxaluria, recurrent urolithiasis or progressive nephrocalcinosis are the principal manifestations. End stage renal failure occurs frequently and is followed by systemic oxalate deposition with its devastating effects. Due to lack of familiarity with the primary hyperoxalurias and their heterogeneous clinical expression, the diagnosis is often delayed until there is advanced disease. In recent years, improvements in medical management have been associated with better patient outcomes. Though there are several therapeutic options that can help to prevent early kidney failure, to date the only curative treatment is combined liver-kidney transplantation in those patients with type I primary hyperoxaluria. Promising areas of investigation are being identified. Knowledge of the spectrum of disease expression, early diagnosis, and initiation of treatment before renal failure ensues are essential to realize a benefit for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6
Jiang, Z., Asplin, J. R., Evan, A. P., Rajendran, V. M., Velazquez, H., Nottoli, T. P., Binder, H. J., & Aronson, P. S. (2006) · Nature Genetics · doi:10.1038/ng1762 · Cited by 324
Hamm, L. L. (1990) · Kidney International · doi:10.1038/ki.1990.265 · Cited by 309
Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion
Hatch, M., Cornelius, J., Allison, M., Sidhu, H., Peck, A., & Freel, R. W. (2006) · Kidney International · doi:10.1038/sj.ki.5000162 · Cited by 245
Linkage disequilibrium mapping in isolated populations: The example of Finland revisited
de la Chapelle, A., & Wright, F. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12416 · Cited by 243
LEUMANN, E., & HOPPE, B. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1291986 · Cited by 228
Self-citationOxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
Hoppe, B., Beck, B., Gatter, N., von Unruh, G., Tischer, A., Hesse, A., Laube, N., Kaul, P., & Sidhu, H. (2006) · Kidney International · doi:10.1038/sj.ki.5001707 · Cited by 215
Self-citationA United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria
Hoppe, B., & Langman, C. B. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1234-x · Cited by 188
Self-citationMilliner, D. S., Eickholt, J. T., Bergstralh, E. J., Wilson, D. M., & Smith, L. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312304 · Cited by 182
Self-citationPrimary hyperoxaluria type 1 in The Netherlands: prevalence and outcome
van Woerden, C. S. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.273 · Cited by 180
Jamieson, N. V. (2005) · American Journal of Nephrology · doi:10.1159/000086359 · Cited by 158
International Registry for Primary Hyperoxaluria
Lieske, J. C., Monico, C. G., Holmes, W. S., Bergstralh, E. J., Slezak, J. M., Rohlinger, A. L., Olson, J. B., & Milliner, D. S. (2005) · American Journal of Nephrology · doi:10.1159/000086360 · Cited by 150
Self-citationPrimary hyperoxaluria type 1: still challenging!
Cochat, P., Liutkus, A., Fargue, S., Basmaison, O., Ranchin, B., & Rolland, M.-O. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0124-4 · Cited by 146
Management of primary hyperoxaluria: efficacy of oral citrate administration
Leumann, E., Höppe, B., & Neuhaus, T. J. (1993) · Pediatric Nephrology · doi:10.1007/bf00864405 · Cited by 130
Intestinal transport of an obdurate anion: oxalate
Hatch, M., & Freel, R. W. (2004) · Urological Research · doi:10.1007/s00240-004-0445-3 · Cited by 128
The Primary Hyperoxalurias: An Algorithm for Diagnosis
Milliner, D. S. (2005) · American Journal of Nephrology · doi:10.1159/000085407 · Cited by 106
Self-citationOxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure
Höppe, B., Graf, D., Offner, G., Latta, K., Byrd, D. J., Michalk, D. V., & Brodehl, J. (1996) · Pediatric Nephrology · doi:10.1007/s004670050145 · Cited by 101
Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases
Blau, N., Leonard, J. V., Hoffmann, G. F., & Clarke, J. T. R. (2006) · Springer eBooks · doi:10.1007/3-540-28962-3 · Cited by 91
Donaldson, J. C., Dise, R. S., Ritchie, M. D., & Hanks, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111697200 · Cited by 83
Long‐term results of pre‐emptive liver transplantation in primary hyperoxaluria type 1
Nolkemper, D., Kemper, M. J., Burdelski, M. M., Vaismann, I., Rogiers, X., Broelsch, C. E., Ganschow, R., & Müller‐Wiefel, D. E. (2000) · Pediatric Transplantation · doi:10.1034/j.1399-3046.2000.00107.x · Cited by 76
Primary Hyperoxaluria – The German Experience
Höppe, B., Latta, K., von Schnakenburg, C., & Kemper, M. J. (2005) · American Journal of Nephrology · doi:10.1159/000086358 · Cited by 71
Molecular Aetiology of Primary Hyperoxaluria Type 1
Danpure, C. J. (2004) · Nephron Experimental Nephrology · doi:10.1159/000080254 · Cited by 66
Urinary oxalate and glycolate excretion in healthy infants and children
Leumann, E., Dietl, A., & Matasovic, A. (1990) · Pediatric Nephrology · doi:10.1007/bf00869828 · Cited by 63
Sikora, P., Unruh, G. E. V., Beck, B. B., Feldkötter, M., Zajączkowska, M., Hesse, A., & Höppe, B. (2008) · Kidney International · doi:10.1038/ki.2008.63 · Cited by 57
Self-citationde Lorenzo, V., Alvarez, A., Torres, A., Torregrosa, V., Hernández, D., & SALIDO, E. C. (2006) · Kidney International · doi:10.1038/sj.ki.5001758 · Cited by 56
Plasma and Urine Glycolate Assays for Differentiating the Hyperoxaluria Syndromes
Marangella, M., Petrarulo, M., Vitale, C., Cosseddu, D., & Linari, F. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36796-4 · Cited by 45
Danpure, C. J., Lumb, M. J., Birdsey, G. M., & Zhang, X. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00055-4 · Cited by 40
Primary Hyperoxaluria Type 1 in Japan
Takayama, T., Nagata, M., Ichiyama, A., & Ozono, S. (2005) · American Journal of Nephrology · doi:10.1159/000086361 · Cited by 26
Cited by
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion
Mulay, S. R., Kulkarni, O. P., Rupanagudi, K. V., Migliorini, A., Darisipudi, M. N., Vilaysane, A., Muruve, D., Shi, Y., Munro, F., Liapis, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63679 · Cited by 468
Worcester, E. M., & Coe, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001011 · Cited by 412
Metadata
- Authors
- Hoppe, B., Beck, B. B., & Milliner, D. S.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 75
- Issue
- 12
- Pages
- 1264-1271
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2053992229
- Cited by
- 375
- References
- 27
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.